Vivos Therapeutics 

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$4,054
$3,419
$3,248
$3,301
Gross Profit
2,506
1,937
1,789
1,898
EBITDA
-1,791
-2,157
-4,135
-4,788
EBIT
-1,936
-2,303
-4,284
-4,938
Net Income
-1,930
-3,763
-4,259
-2,093
Net Change In Cash
4,054
3,419
3,248
3,301
Free Cash Flow
-3,108
-2,667
-2,913
-2,954
Cash
6,903
2,611
1,643
988
Basic Shares
3,228
2,308
1,833
1,197

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$13,801
$16,024
$16,885
$13,066
Gross Profit
7,650
10,019
12,604
10,412
EBITDA
-16,675
-24,463
-18,630
-11,242
EBIT
-17,296
-25,132
-19,363
-11,960
Net Income
-13,583
-22,659
-20,293
-8,822
Net Change In Cash
13,801
16,024
16,885
13,066
Free Cash Flow
-12,799
-20,511
-18,131
-5,800
Cash
1,643
3,519
24,030
18,205
Basic Shares
1,219
920
849
728

Earnings Calls

Quarter EPS
2024-06-30
-$0.60
2024-03-31
-$1.63
2023-12-31
-$3.05
2023-09-30
-$1.62